BlackRock, Inc. 13D and 13G filings for Ovid Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-29 5:25 pm Purchase |
2023-12-31 | 13G | Ovid Therapeutics Inc. OVID |
BlackRock Inc. BLK |
4,319,918 6.100% |
3,117,188 (+259.18%) |
Filing |
| 2021-07-12 08:29 am Sale |
2021-06-30 | 13G | Ovid Therapeutics Inc. OVID |
BlackRock Inc. BLK |
1,202,730 1.800% |
-2,209,003 (-64.75%) |
Filing |
| 2021-02-02 3:13 pm Purchase |
2020-12-31 | 13G | Ovid Therapeutics Inc. OVID |
BlackRock Inc. BLK |
3,411,733 5.400% |
2,756,291 (+420.52%) |
Filing |